BRPI0911364A2 - tienopirimidinas - Google Patents
tienopirimidinasInfo
- Publication number
- BRPI0911364A2 BRPI0911364A2 BRPI0911364A BRPI0911364A BRPI0911364A2 BR PI0911364 A2 BRPI0911364 A2 BR PI0911364A2 BR PI0911364 A BRPI0911364 A BR PI0911364A BR PI0911364 A BRPI0911364 A BR PI0911364A BR PI0911364 A2 BRPI0911364 A2 BR PI0911364A2
- Authority
- BR
- Brazil
- Prior art keywords
- thienopyrimidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008017853A DE102008017853A1 (de) | 2008-04-09 | 2008-04-09 | Thienopyrimidine |
| PCT/EP2009/002112 WO2009124653A2 (de) | 2008-04-09 | 2009-03-23 | Thienopyrimidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0911364A2 true BRPI0911364A2 (pt) | 2015-12-29 |
Family
ID=40765631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0911364A BRPI0911364A2 (pt) | 2008-04-09 | 2009-03-23 | tienopirimidinas |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110028472A1 (pt) |
| EP (1) | EP2260044A2 (pt) |
| JP (1) | JP2011518132A (pt) |
| KR (1) | KR20110010721A (pt) |
| CN (1) | CN102015724A (pt) |
| AR (1) | AR071586A1 (pt) |
| AU (1) | AU2009235729A1 (pt) |
| BR (1) | BRPI0911364A2 (pt) |
| CA (1) | CA2720878A1 (pt) |
| DE (1) | DE102008017853A1 (pt) |
| EA (1) | EA201001576A1 (pt) |
| IL (1) | IL208066A0 (pt) |
| MX (1) | MX2010011015A (pt) |
| WO (1) | WO2009124653A2 (pt) |
| ZA (1) | ZA201007979B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2766193A1 (en) * | 2009-06-22 | 2010-12-29 | Merck Patent Gmbh | Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators |
| PH12012500778A1 (en) | 2009-10-30 | 2012-11-26 | Janssen Pharmaceutica Nv | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| EP2531500B1 (en) | 2010-02-05 | 2018-01-24 | Merck Patent GmbH | Hetaryl-[1,8]naphthyridine derivatives |
| BR112012019561A2 (pt) | 2010-02-22 | 2019-09-24 | Merck Patent Gmbh | hetarilamino naftiridinas |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| JP6115962B2 (ja) | 2011-06-27 | 2017-04-19 | ヤンセン ファーマシューティカ エヌ．ベー． | １−アリール−４−メチル−［１，２，４］トリアゾロ［４，３−ａ］キノキサリン誘導体 |
| FR2988722B1 (fr) | 2012-04-03 | 2014-05-09 | Sanofi Sa | Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques |
| WO2014001314A1 (en) | 2012-06-26 | 2014-01-03 | Janssen Pharmaceutica Nv | Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders |
| AU2013289284B2 (en) | 2012-07-09 | 2017-03-30 | Janssen Pharmaceutica Nv | Inhibitors of phosphodiesterase 10 enzyme |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| EP1187633A4 (en) | 1999-04-08 | 2005-05-11 | Arch Dev Corp | USE OF ANTI-VEGF ANTIBODIES TO ENHANCE RADIATION IN ANTICANCER THERAPY |
| TW200538120A (en) * | 2004-02-20 | 2005-12-01 | Kirin Brewery | Compound having TGF-beta inhibitory activity and pharmaceutical composition containing same |
| WO2006090094A1 (en) * | 2005-02-28 | 2006-08-31 | Vernalis R & D Ltd | Pyrimidothiophene compounds for use as hsp90 inhibitors |
| DE102005013621A1 (de) * | 2005-03-24 | 2006-09-28 | Curacyte Discovery Gmbh | Substituierte 2-Aryl(Hetaryl)-5-aminothieno[2,3-d]pyrimidin-6-carbonsäureamide, Verfahren zu ihrer Herstellung und Verwendung als Pharmazeutika |
| JP2009523805A (ja) * | 2006-01-17 | 2009-06-25 | シグナル ファーマシューティカルズ，エルエルシー | ＴＮＦα、ＰＤＥ４及びＢ−ＲＡＦの阻害剤、それらの組成物及びそれらの使用法 |
| JPWO2008020622A1 (ja) * | 2006-08-17 | 2010-01-07 | 杏林製薬株式会社 | 新規なチエノ［２，３−ｄ］ピリミジン化合物 |
-
2008
- 2008-04-09 DE DE102008017853A patent/DE102008017853A1/de not_active Withdrawn
-
2009
- 2009-03-23 AU AU2009235729A patent/AU2009235729A1/en not_active Abandoned
- 2009-03-23 JP JP2011503357A patent/JP2011518132A/ja active Pending
- 2009-03-23 CA CA2720878A patent/CA2720878A1/en not_active Abandoned
- 2009-03-23 EP EP09731280A patent/EP2260044A2/de not_active Withdrawn
- 2009-03-23 MX MX2010011015A patent/MX2010011015A/es not_active Application Discontinuation
- 2009-03-23 WO PCT/EP2009/002112 patent/WO2009124653A2/de not_active Ceased
- 2009-03-23 KR KR1020107025024A patent/KR20110010721A/ko not_active Withdrawn
- 2009-03-23 CN CN2009801122450A patent/CN102015724A/zh active Pending
- 2009-03-23 BR BRPI0911364A patent/BRPI0911364A2/pt not_active Application Discontinuation
- 2009-03-23 EA EA201001576A patent/EA201001576A1/ru unknown
- 2009-03-23 US US12/937,031 patent/US20110028472A1/en not_active Abandoned
- 2009-04-08 AR ARP090101244A patent/AR071586A1/es unknown
-
2010
- 2010-09-07 IL IL208066A patent/IL208066A0/en unknown
- 2010-11-08 ZA ZA2010/07979A patent/ZA201007979B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL208066A0 (en) | 2010-12-30 |
| WO2009124653A3 (de) | 2009-12-03 |
| DE102008017853A1 (de) | 2009-10-15 |
| MX2010011015A (es) | 2010-11-22 |
| WO2009124653A2 (de) | 2009-10-15 |
| CA2720878A1 (en) | 2009-10-15 |
| JP2011518132A (ja) | 2011-06-23 |
| KR20110010721A (ko) | 2011-02-07 |
| EP2260044A2 (de) | 2010-12-15 |
| ZA201007979B (en) | 2011-07-27 |
| CN102015724A (zh) | 2011-04-13 |
| US20110028472A1 (en) | 2011-02-03 |
| AR071586A1 (es) | 2010-06-30 |
| EA201001576A1 (ru) | 2011-04-29 |
| AU2009235729A1 (en) | 2009-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3988147C0 (en) | INSERT SET | |
| DK2370462T3 (da) | Glucagon-analoger | |
| DK2342317T3 (da) | Hængende-dråbe-plade | |
| DE602009000234D1 (de) | msignals | |
| BRPI0907376A2 (pt) | Fotobiorretador | |
| DK3444343T3 (da) | Polypeptider | |
| BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
| DE602008003972D1 (de) | Sitzrücklehnungsmechanismus | |
| DE602008003521D1 (de) | Sitzrücklehnungsmechanismus | |
| DK2342454T3 (da) | Vindkraftanlæg | |
| DK2336132T3 (da) | Morpholinpurinderivat | |
| DK2335031T3 (da) | In-line-måler | |
| DK2379557T3 (da) | Aminopyrazol-forbindelse | |
| DK2271613T3 (da) | Hydroxymethylcyklohexylaminer | |
| DE602008003970D1 (de) | Strahlstromkalibriersystem | |
| EP2257170A4 (en) | TETRAHYDROFUROPYRIDONE | |
| BRPI0907522A2 (pt) | biarlamidas | |
| EP2248964A4 (en) | DRILLING / TERMINAL DEVICE | |
| DE112009000183A5 (de) | Sicherheitsvorreiber | |
| EP2261152A4 (en) | REEL | |
| BRPI0909634A2 (pt) | 2-aminoquinolinas | |
| DE602009000862D1 (de) | Gehwagenbremse | |
| DE112009001946A5 (de) | Mobelauszugsführung | |
| DE602009000488D1 (de) | Obstvereinzelvorrichtung | |
| BRPI0907863A2 (pt) | pirrolopirimidinacarboxamidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |